Immunohistochemical Markers in Hepatocellular Carcinoma Diagnosis
Summary
In hepatocellular carcinoma diagnosis, immunohistochemical markers provide crucial molecular signatures for distinguishing malignant hepatocytes from benign liver lesions and metastatic tumours. The technique relies on antibodies against lineage-specific, differentiation and oncofetal antigens to visualise protein expression in formalin-fixed paraffin-embedded tissue. Panels combining hepatocytic markers such as hepatocyte paraffin-1 and arginase-1 with malignant phenotypes including glypican-3, heat shock protein 70 and glutamine synthetase have achieved high sensitivity and specificity in core needle biopsies and fine-needle aspirates. Emerging specialised assays such as α-fetoprotein mRNA RNAscope further enhance detection, particularly in poorly differentiated tumours. Recent advances have also identified subtype-specific signatures, for example gastric-type hepatocellular carcinoma characterised by co-expression of VSIG1 and thyroid transcription factor 1 with vimentin negativity. Incorporation of immunohistochemical profiles into diagnostic algorithms has improved early detection of small and ambiguous nodules, refined prognostic stratification and guided tailored therapeutic strategies worldwide.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Immunohistochemical Markers in Hepatocellular Carcinoma Diagnosis publication trend
The graph below shows the total number of articles in immunohistochemical markers in hepatocellular carcinoma diagnosis across all publications each year (not limited to Nature Index journals).
Technical terms
Immunohistochemistry (IHC): A laboratory technique that uses antibodies to detect specific antigens in tissue sections, producing visual markers for diagnostic evaluation.
Glypican-3 (GPC3): An oncofetal cell surface proteoglycan overexpressed in HCC and used as a marker of malignant hepatocyte proliferation.
Hepatocyte paraffin-1 (HepPar-1): A mitochondrial enzyme marker specific for hepatocytic differentiation employed to confirm hepatocyte lineage.
Arginase-1 (Arg-1): A liver-specific enzyme involved in the urea cycle, used for its high sensitivity and specificity in identifying hepatocellular carcinoma.
α-Fetoprotein (AFP) mRNA RNAscope: An in situ hybridisation assay that detects AFP transcripts at single-molecule sensitivity, enhancing diagnostic precision for hepatocytic malignancy.
VSIG1: A cell adhesion molecule whose co-expression with TTF-1 identifies a gastric-type subtype of hepatocellular carcinoma.
References
- Gastric-Type Expression Signature in Hepatocellular Carcinoma. International Journal of Molecular Sciences (2024).
- α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study. British Journal of Cancer (2021).
- Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors. International Journal of Molecular Sciences (2021).
- Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.. International Journal of Oncology (2009).
- Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How. Frontiers in Medicine (2017).
- Hepatocyte paraffin 1 and arginase-1 are effective panel of markers in HBV-related HCC diagnosis in fine-needle aspiration specimens. BMC Research Notes (2020).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.